Livalo Dosage & Drug Information

Concise Prescribing Info

Contents

Pitavastatin Ca

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Indications/Uses

Primary hyperlipidemia including familial hypercholesterolaemia or mixed dyslipidemia as an adjunctive therapy to diet to reduce elevated total cholesterol (TC), LDL-C, Apo-B, triglycerides & to increase HDL-C. Familial hypercholesterolemia in childn ≥10 yr when response to diet & other non-pharmacological measures are inadequate.

Dosage/Direction for Use

Adult Starting dose: 20 mg once daily. May be increased to max 4 mg daily when lowering of the LDL-C level is insufficient. Dose adjustment should be made at ≥4-wk intervals. Moderate & severe renal impairment (GFR 30-59 & 15-29 mL/min/1.73 m²) & ESRD receiving hemodialysis Starting dose: 1 mg once daily. Max dose: 2 mg once daily. Childn ≥10 yr 1 mg once daily. May be increased to max 2 mg daily when lowering of LDL-C level is insufficient. Dose adjustment should be made at ≥4-wk intervals.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity. Patients w/ active liver disease or unexplained persistent elevations in serum transaminases; myopathy; receiving concomitant ciclosporin. Women of child bearing potential not taking appropriate contraceptive. Pregnancy & lactation.

MIMS Class

Dyslipidaemic Agents

ATC Classification

C10AA08 - pitavastatin ; Belongs to the class of HMG CoA reductase inhibitors. Used in the treatment of hyperlipidemia.

Regulatory Classification

POM

Presentation/Packing

Form

Livalo FC tab 2 mg

Packing/Price

1's

Form

Livalo FC tab 4 mg

Packing/Price

1's

Livalo

pitavastatin

Manufacturer:

Kowa